Zhejiang Huakang Pharmaceutical Co Ltd
SSE:605077
Wall Street
Price Targets
Price Targets Summary
Zhejiang Huakang Pharmaceutical Co Ltd
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Zhejiang Huakang Pharmaceutical Co Ltd's stock price target?
Not Available
Zhejiang Huakang Pharmaceutical Co Ltd doesn't have any price targets made by Wall Street professionals.
What is Zhejiang Huakang Pharmaceutical Co Ltd's Revenue forecast?
Projected CAGR
33%
For the last 6 years the compound annual growth rate for Zhejiang Huakang Pharmaceutical Co Ltd's revenue is 12%. The projected CAGR for the next 3 years is 33%.
What is Zhejiang Huakang Pharmaceutical Co Ltd's Operating Income forecast?
Projected CAGR
35%
For the last 6 years the compound annual growth rate for Zhejiang Huakang Pharmaceutical Co Ltd's operating income is 5%. The projected CAGR for the next 3 years is 35%.
What is Zhejiang Huakang Pharmaceutical Co Ltd's Net Income forecast?
Projected CAGR
30%
For the last 6 years the compound annual growth rate for Zhejiang Huakang Pharmaceutical Co Ltd's net income is 5%. The projected CAGR for the next 3 years is 30%.